HER-2 oncogene amplification assessment in invasive breast cancer by dual-color in situ hybridization (dc-CISH): A comparative study with fluorescent in situ hybridization (FISH).;Détermination de l'amplification de l'oncogène HER-2 dans le cancer du sein invasif par hybridation chromogénique in situ double couleur (dc-CISH): Étude comparative avec l'hybridation fluorescente in situ (FISH)

Annales de Pathologie

Volumn 31, Issue 6, 2011, Pages 472-479

  Akhdar, Abbas ^a   Bronsard, Marc ^a   Lemieux, Renald ^b   Geha, Sameh ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^b Direction de l'ETMIS (evaluation de la technologie et des modes d'intervention en sante) du CHUS   (Canada)

Author keywords

Breast cancer; Dc CISH; Dual color; FISH; HER 2

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DUAL COLOR IN SITU HYBRIDIZATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; IN SITU HYBRIDIZATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PATHOLOGIST; TISSUE MICROARRAY;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; FLUORESCENT DYES; GENE AMPLIFICATION; GENES, ERBB-2; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGE PROCESSING, COMPUTER-ASSISTED; IN SITU HYBRIDIZATION; IN SITU HYBRIDIZATION, FLUORESCENCE; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; REPRODUCIBILITY OF RESULTS; STAINING AND LABELING;

EID: 83555161722     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annpat.2011.10.013     Document Type: Article

References (24)

1. Couturier J., Vincent-Salomon A., Mathieu M.C., Valent A., Bernheim A. Diagnosis of HER-2 gene amplification in breast carcinoma. Pathol Biol (Paris) 2008, 56:375-379.
2. Baselga J. Treatment of HER-2-overexpressing breast cancer. Ann Oncol 2010, 21:vii36-vii40.
3. Schmitt F. HER-2+breast cancer: how to evaluate?. Adv Ther 2009, 26:S1-S8.
4. Ross J.S., Schenkein D.P., Pietrusko R., et al. Targeted therapies for cancer 2004. Am J Clin Pathol 2004, 122:598-609.
5. Kurosumi M. Recent trends of HER-2 testing and trastuzumab therapy for breast cancer. Breast Cancer 2009, 16:284-287.
6. Penault-Llorca F., Vincent-Salomon A., Bellocq J.P., Matthieu M.C., Grogan G.M., Treilleux I., et al. Mise à jour des recommandations du GEFPICS pour l'évaluation du statut HER-2 dans les cancers du sein en France. Ann Pathol 2010, 30:357-373.
7. Wolff A.C., Hammond M.E., Schwartz J.N., Hagerty K.L., Allred D.C., Cote R.J., et al. American society of clinical oncology/College of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 2007, 131:18-43.
8. Hanna W., O'Malley F.P., Barnes P., Berendt R., Gaboury L., Magliocco A., et al. Updated recommendations from the Canadian national consensus meeting on HER-2/neu testing in breast cancer. Curr Oncol 2007, 14:149-153.
9. Garcia-Caballero T., Grabau D., Green A.R., Gregory J., Schad A., Kohlwes E., et al. Determination of HER-2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens. Histopathology 2010, 56:472-480.
10. Lambros M.B., Natrajan R., Reis-Filho J.S. Chromogenic and fluorescent in situ hybridization in breast cancer. Hum Pathol 2007, 38:1105-1122.
11. Laakso M., Tanner M., Isola J. Dual-colour chromogenic in situ hybridization for testing of HER-2 oncogene amplification in archival breast tumours. J Pathol 2006, 210:3-9.
12. Pedersen M., Rasmussen B.B. The correlation between dual-color chromogenic in situ hybridization and fluorescence in situ hybridization in assessing HER-2 gene amplification in breast cancer. Diagn Mol Pathol 2009, 18:96-102.
13. Shipley J. Putting the colours into chromogenic in situ hybridization (CISH). J Pathol 2006, 210:1-2.
14. Mayr D., Heim S., Weyrauch K., Zeindl-Eberhart E., Kunz A., Engel J., et al. Chromogenic in situ hybridization for HER-2/neu-oncogene in breast cancer: comparison of a new dual-colour chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization. Histopathology 2009, 55:716-723.
15. Kato N., Itoh H., Serizawa A., Hatanaka Y., Umemura S., Osamura R.Y. Evaluation of HER-2 gene amplification in invasive breast cancer using a dual-color chromogenic in situ hybridization (dual CISH). Pathol Int 2010, 60:510-515.
16. Bai Y.F., Ren G.P., Wang B., Teng L.S., Liu X. Comparison between analysis of HER-2 gene and chromosome 17 in breast cancer by dual-probe chromogenic in situ hybridization and fluorescence in situ hybridization. Zhonghua Bing Li Xue Za Zhi 2010, 39:161-165.
17. Hoff K., Jorgensen J.T., Muller S., Rongaard E., Rasmussen O., Schonau A. Visualization of FISH probes by dual-color chromogenic in situ hybridization. Am J Clin Pathol 2010, 133:205-211.
18. Pothos A., Plastira K., Plastiras A., Vlachodimitropoulos D., Goutas N., Angelopoulou R. Comparison of chromogenic in situ hybridisation with fluorescence in situ hybridization and immunohistochemistry for the assessment of HER-2/neu oncogene in archival material of breast carcinoma. Acta Histochem Cytochem 2008, 41:59-64.
19. Hannah W., Kwok K. Chromogenic in situ hybridization: a viable alternative to fluorescence in situ hybridization in the HER-2 testing algorithm. Modern Pathology 2006, 19:481-487.
20. Zhao J., Wu R., et al. Determination of HER-2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma. Mod Pathol 2002, 15:657-665.
21. Koh Y.W., Lee H.J., Lee J.W., Kang J., Gong G.L. Dual-color silver-enhanced in situ hybridization for assessing HER-2 gene amplification in breast cancer. Mod Pathol 2011, 24:794-800.
22. Carbone A., Botti G., Gloghini A., Simone G., Truini M., Curcio M.P., et al. Delineation of HER-2 gene status in breast carcinoma by silver in situ hybridization is reproducible among laboratories and pathologists. J Mol Diagn 2008, 10:527-536.
23. Papouchado B., Myles J., Lloyd R.V., Stoler M., Oliveira A.M., Downs-Kelly E., et al. Silver in situ hybridization (SISH) for determination of HER-2 gene status in breast carcinoma: comparison with FISH and assessment of interobserver reproducibility. Am J Surg Pathol 2010, 34:767-776.
24. Powell R., Pettay J., Powell W.C., Roche P.C., Grogan T.M., Hainfeld J.F., et al. Metallographic in situ hybridization. Hum Pathol 2007, 38:1145-1159.